title: Withaferin A Induces ROS-Mediated Paraptosis in Human Breast Cancer Cell-Lines MCF-7 and MDA-MB-231.
abstract: Advancement in cancer therapy requires a better understanding of the detailed mechanisms that induce death in cancer cells. Besides apoptosis, themode of other types of cell death has been increasingly recognized in response to therapy. Paraptosis is a non-apoptotic alternative form of programmed cell death, morphologically) distinct from apoptosis and autophagy. In the present study, Withaferin-A (WA) induced hyperpolarization of mitochondrial membrane potential and formation of many cytoplasmic vesicles. This was due to progressive swelling and fusion of mitochondria and dilation of endoplasmic reticulum (ER), forming large vacuolar structures that eventually filled the cytoplasm in human breast cancer cell-lines MCF-7 and MDA-MB-231. The level of indigenous paraptosis inhibitor, Alix/AIP-1 (Actin Interacting Protein-1) was down-regulated by WA treatment. Additionally, prevention of WA-induced cell death and vacuolation on co-treatment with protein-synthesis inhibitor indicated requirement of de-novo protein synthesis. Co-treatment with apoptosis inhibitor resulted in significant augmentation of WA-induced death in MCF-7 cells, while partial inhibition in MDA-MB-231 cells; implyingthat apoptosis was not solely responsible for the process.WA-mediated cytoplasmic vacuolationcould not be prevented by autophagy inhibitor wortmanninas well, claiming this process to be a non-autophagic one. Early induction of ROS (Reactive Oxygen Species)by WA in both the cell-lines was observed. ROS inhibitorabrogated the effect of WA on: cell-death, expression of proliferation-associated factor andER-stress related proteins,splicing of XBP-1 (X Box Binding Protein-1) mRNA and formation of paraptotic vacuoles.All these results conclusively indicate thatWA induces deathin bothMCF-7 and MDA-MB-231 cell lines byROS-mediated paraptosis.
authors.affiliation: Department of Biophysics, Molecular Biology and Bioinformatics, University of Calcutta, India.
authors.forename: Kamalini
authors.initials: K
authors.lastname: Ghosh
authors.affiliation: Department of Biophysics, Molecular Biology and Bioinformatics, University of Calcutta, India.
authors.forename: Soumasree
authors.initials: S
authors.lastname: De
authors.affiliation: Department of Biophysics, Molecular Biology and Bioinformatics, University of Calcutta, India.
authors.forename: Sayantani
authors.initials: S
authors.lastname: Das
authors.affiliation: Department of Biophysics, Molecular Biology and Bioinformatics, University of Calcutta, India.
authors.forename: Srimoyee
authors.initials: S
authors.lastname: Mukherjee
authors.affiliation: Department of Biophysics, Molecular Biology and Bioinformatics, University of Calcutta, India.
authors.forename: Sumita
authors.initials: S
authors.lastname: Sengupta Bandyopadhyay
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D001343:Autophagy / Q000187:drug effects; D001943:Breast Neoplasms / Q000473:pathology*; D061945:Caspase Inhibitors / Q000494:pharmacology; D020169:Caspases / Q000378:metabolism; D006801:Humans; D061986:MCF-7 Cells; D053078:Membrane Potential, Mitochondrial / Q000187:drug effects; D018384:Oxidative Stress / Q000187:drug effects; D017382:Reactive Oxygen Species / Q000378:metabolism*; D014617:Vacuoles / Q000187:drug effects / Q000378:metabolism; D054358:Withanolides / Q000494:pharmacology*
chemical_list: D000970:Antineoplastic Agents; D061945:Caspase Inhibitors; D017382:Reactive Oxygen Species; D054358:Withanolides; D020169:Caspases; C009684:withaferin A